PRODUCTS & INNOVATION
Andrea Wainer is Abbott’s Executive Vice President, Rapid and Molecular Diagnostics. She was appointed to this role in June 2019.
Andrea joined Abbott in 1997 and served in a variety of roles within our pharmaceuticals business, including divisional vice president and general manager, renal care. She then led our Animal Health business, which was acquired by Zoetis in February 2015. Immediately prior to assuming her current responsibilities, Andrea served as Vice President, Molecular Diagnostics.
In her current role, Andrea leads two innovative businesses; one a leader in molecular diagnostics and the analysis of DNA and RNA at the molecular level; the other the world’s leading provider of rapid point-of-care diagnostics. Each of these offers products that provide clinicians with actionable information that can contribute to better clinical, operational and economic outcomes.
Andrea earned her bachelor’s degree in accounting from the John M. Olin School of Business, Washington University, St. Louis, Missouri, and her Masters in Business Administration from the Kellogg School of Management, Northwestern University in Evanston, Illinois.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.